(VIANEWS) - Pimco Corporate & Income Strategy Fund (PCN), ONEOK (OKE), Walgreens Boots (WBA) have the highest dividend yield stocks on this list.
| Rank | Financial Asset | Price | Change | Forward Dividend Yield | Updated (EST) |
|---|---|---|---|---|---|
| 1 | Pimco Corporate & Income Strategy Fund (PCN) | 11.51 | -2.46% | 11.44% | 2022-12-28 19:55:28 |
| 2 | ONEOK (OKE) | 66.76 | 2.98% | 6.4% | 2023-01-08 08:18:08 |
| 3 | Walgreens Boots (WBA) | 36.54 | 3.85% | 5.41% | 2023-01-08 08:08:03 |
| 4 | First Foundation (FFWM) | 14.33 | -0.49% | 3.07% | 2023-01-01 13:23:07 |
| 5 | Bristol (BMY) | 72.90 | 1.37% | 2.9% | 2023-01-08 03:14:02 |
| 6 | Air Products and Chemicals (APD) | 310.00 | 2.71% | 2.6% | 2023-01-08 08:06:05 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Pimco Corporate & Income Strategy Fund (PCN) - Dividend Yield: 11.44%
Pimco Corporate & Income Strategy Fund's last close was $11.51, 34.27% below its 52-week high of $17.51.
PIMCO Corporate & Income Strategy Fund is a closed-ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It invests in the fixed income markets of the United States. The fund invests in securities of companies that operate across diversified sectors. It invests in fixed income securities such as treasury bonds, corporate notes, U.S. government agency securities, mortgage backed and asset-backed securities. The fund employs fundamental analysis with a top-down security selection process to create its portfolio. The fund was formerly known as PIMCO Corporate Income Fund. PIMCO Corporate & Income Strategy Fund was formed on October 17, 2001 and is domiciled in the United States.
Earnings per Share
Pimco Corporate & Income Strategy Fund's trailing 12 months EPS is $0.84.
PE Ratio
Pimco Corporate & Income Strategy Fund's trailing 12-month price-to-earnings ratio is 13.7. The purchaser of the shares is investing $13.7 per dollar in annual earnings.
More news about Pimco Corporate & Income Strategy Fund.
2. ONEOK (OKE) - Dividend Yield: 6.4%
ONEOK's last close was $66.57, 11.32% under its 52-week high of $75.07.
ONEOK, Inc. and its subsidiaries engage in natural gas gathering, processing, storage, transportation, and transport in the United States. The company operates in three segments: Natural Gas Gathering and Processing and Natural Gas Liquids and Natural Gas Pipelines. It owns processing plants and natural gas gathering pipes in the Rocky Mountain and Mid-Continent regions. The company also collects, transports, splits and treats natural gas liquids (NGL). It markets and sells NGL products. It owns NGL collection and distribution pipelines that it operates in Oklahoma, Kansas and Texas. It also operates natural gas storage and transmission facilities and regulated interstate and intrastate natural gaz pipelines. The company also owns and manages a downtown parking garage in Tulsa, Oklahoma. It leases out excess office space. The company owns and operates 17500 miles of natural-gas gathering pipelines, 1,500 mile of FERC-regulated interstate pipelines, 5,100 miles state-regulated intrastate transmission pipes; six NGL storage units; eight NGL product terminals. The company serves independent and integrated exploration and production firms; NGL gathering and processing businesses; crude oil production and distribution companies; municipal governments; propane producers; and NGL, refining and NGL marketing and distribution companies. It was established in 1906 in Tulsa in Oklahoma.
Earnings per Share
ONEOK's trailing 12 month EPS is $2.59.
PE Ratio
ONEOK's trailing 12 months earnings to price ratio is 25.81. The purchaser of the shares is therefore investing $25.81 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 26.23%.Sales Growth
ONEOK's sales growth for the next quarter is 18.7%.
More news about ONEOK.
3. Walgreens Boots (WBA) - Dividend Yield: 5.41%
Walgreens Boots's last close was $36.61, 33.44% below its 52-week high of $55.00.
Walgreens Boots Alliance, Inc. operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides health and wellness, and specialty and home delivery pharmacy services. As of August 31, 2022, this segment operated 8,886 retail stores under the Walgreens and Duane Reade brands in the United States; and 3 specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2022, this segment operated 3,989 retail stores under the Boots, Benavides, and Ahumada brands in the United Kingdom, Thailand, the Republic of Ireland, and Chile; and 543 optical practices, including 160 on a franchise basis. The U.S. Healthcare segment provides value-based primary care services; post-acute and home care management services; and clinical healthcare services. It also operates as a specialty pharmacy integrator and accelerator for hospitals. As of August 31, 2022, this segment operated 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Earnings per Share
Walgreens Boots' trailing 12 month EPS is $-0.71.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was 14.9%.Annual Top and Bottom Value
Walgreens Boots' stock was valued at $36.54 as of 02:15 EST. This is way below its 52 week high of $55.00, and far above its low 52-week of $30.39.
More news about Walgreens Boots.
4. First Foundation (FFWM) - Dividend Yield: 3.07%
First Foundation's last close was $14.33, 48.84% under its 52-week high of $28.01.
Through its subsidiaries, First Foundation Inc. provides private banking services, as well as business banking and personal wealth management services, in the United States. The company operates in two distinct segments: Banking and Wealth Management. There are a variety of deposit options available to customers, including savings, personal checking and business accounts as well as interest-bearing, negotiable orders of withdrawal, time certificates of deposits and loans that include multifamily residential and single family real estate loans as well as commercial terms loans and lines of credit. Consumer loans such as home equity loans and personal line of credit and line loans can also be offered. The company also offers specialized services such as trust services, mobile and internet banking, remote deposit capture, merchant credit card service, ATM cards and Visa debit cards. It also provides insurance brokerage and equipment financing. The company also offers financial planning and investment services, treasury services, advisory and coordination in areas such as estate planning and retirement planning and charitable and corporate ownership, financial, economic, and other related services. It also provides support services such as the transmission and processing of economic and financial data for charities. It operates through 28 branches and three loan production offices located in California, Nevada and Texas. First Foundation Inc. was established in 1985 in Dallas, Texas.
Earnings per Share
First Foundation's trailing 12 months profit per share (EPS) is $2.15
PE Ratio
First Foundation's trailing 12-month price-to-earnings ratio is 6.67. The purchaser of the shares is investing $6.67 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 12.39%.Annual Top and Bottom Value
First Foundation stock was valued at $14.33 as of 02/16 EST. This is way lower than its 52 week high of $28.01 but higher than its 52 week low of $13.17.
Sales Growth
First Foundation saw a 28.4% increase in sales for its current quarter, and 10.3% the following.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 3, 2022, the estimated forward annual dividend rate is 0.44 and the estimated forward annual dividend yield is 3.07%.
Growth Estimates Quarters
For the current quarter, the company expects a decline of 39.6% in growth and 56.4% for the following.More news about First Foundation.
5. Bristol (BMY) - Dividend Yield: 2.9%
Bristol's last close was $73.00, 10.36% below its 52-week high of $81.44.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $-2.76.
More news about Bristol.
6. Air Products and Chemicals (APD) - Dividend Yield: 2.6%
Air Products and Chemicals's last close was $310.18, 5.59% below its 52-week high of $328.56.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasification, metals, manufacturing, food and beverage, electronics, magnetic resonance imaging, energy production and refining, and metals. It also designs and manufactures equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction, and liquid helium and liquid hydrogen transport and storage. Air Products and Chemicals, Inc. has a strategic collaboration with Baker Hughes Company to develop hydrogen compression systems. The company was founded in 1940 and is headquartered in Allentown, Pennsylvania.
Earnings Per Share
As for profitability, Air Products and Chemicals has a trailing twelve months EPS of $8.51.
PE Ratio
Air Products and Chemicals has a trailing twelve months price to earnings ratio of 36.42. Meaning, the purchaser of the share is investing $36.42 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.17%.Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 29, 2022, the estimated forward annual dividend rate is 6.48 and the estimated forward annual dividend yield is 2.6%.
Volatility
Air Products and Chemicals's last week, last month's, and last quarter's current intraday variation average was a positive 0.16%, a negative 0.08%, and a positive 1.39%.
Air Products and Chemicals's highest amplitude of average volatility was 1.23% (last week), 0.91% (last month), and 1.39% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Air Products and Chemicals's stock is considered to be oversold (<=20).
Sales Growth
Air Products and Chemicals's sales growth for the current quarter is 13.5%.
More news about Air Products and Chemicals.